nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—NCOA3—Teniposide—lymphatic system cancer	0.661	0.782	CbGbCtD
Amsacrine—TOP2A—Teniposide—lymphatic system cancer	0.0971	0.115	CbGbCtD
Amsacrine—TOP2A—Mitoxantrone—lymphatic system cancer	0.0679	0.0803	CbGbCtD
Amsacrine—ABCB1—Mitoxantrone—lymphatic system cancer	0.00908	0.0107	CbGbCtD
Amsacrine—ABCB1—Vincristine—lymphatic system cancer	0.00625	0.00739	CbGbCtD
Amsacrine—ABCB1—Methotrexate—lymphatic system cancer	0.00378	0.00448	CbGbCtD
Amsacrine—NCOA3—Gemcitabine—Cytarabine—lymphatic system cancer	0.0012	0.283	CbGdCrCtD
Amsacrine—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.000593	0.14	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.000452	0.107	CbGdCrCtD
Amsacrine—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000427	0.101	CbGdCrCtD
Amsacrine—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.000333	0.00221	CcSEcCtD
Amsacrine—Anorexia—Teniposide—lymphatic system cancer	0.000331	0.0022	CcSEcCtD
Amsacrine—Hepatotoxicity—Methotrexate—lymphatic system cancer	0.000329	0.00218	CcSEcCtD
Amsacrine—Pancytopenia—Carmustine—lymphatic system cancer	0.000327	0.00217	CcSEcCtD
Amsacrine—Hypotension—Teniposide—lymphatic system cancer	0.000325	0.00216	CcSEcCtD
Amsacrine—Convulsion—Fludarabine—lymphatic system cancer	0.000324	0.00215	CcSEcCtD
Amsacrine—Gingivitis—Methotrexate—lymphatic system cancer	0.000323	0.00215	CcSEcCtD
Amsacrine—Necrosis—Methotrexate—lymphatic system cancer	0.000323	0.00215	CcSEcCtD
Amsacrine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.000323	0.00214	CcSEcCtD
Amsacrine—Haemoglobin—Bleomycin—lymphatic system cancer	0.000317	0.0021	CcSEcCtD
Amsacrine—Haemorrhage—Bleomycin—lymphatic system cancer	0.000315	0.00209	CcSEcCtD
Amsacrine—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.000314	0.00208	CcSEcCtD
Amsacrine—Pancytopenia—Vincristine—lymphatic system cancer	0.000312	0.00207	CcSEcCtD
Amsacrine—Dyspnoea—Teniposide—lymphatic system cancer	0.00031	0.00206	CcSEcCtD
Amsacrine—Confusional state—Fludarabine—lymphatic system cancer	0.000308	0.00204	CcSEcCtD
Amsacrine—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.000304	0.00202	CcSEcCtD
Amsacrine—Infection—Fludarabine—lymphatic system cancer	0.000304	0.00201	CcSEcCtD
Amsacrine—Decreased appetite—Teniposide—lymphatic system cancer	0.000302	0.00201	CcSEcCtD
Amsacrine—Renal failure—Carmustine—lymphatic system cancer	0.000301	0.002	CcSEcCtD
Amsacrine—Vomiting—Mechlorethamine—lymphatic system cancer	0.0003	0.00199	CcSEcCtD
Amsacrine—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.000299	0.00199	CcSEcCtD
Amsacrine—Stomatitis—Carmustine—lymphatic system cancer	0.000299	0.00198	CcSEcCtD
Amsacrine—Rash—Mechlorethamine—lymphatic system cancer	0.000297	0.00197	CcSEcCtD
Amsacrine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.000297	0.00197	CcSEcCtD
Amsacrine—Weight decreased—Vincristine—lymphatic system cancer	0.000297	0.00197	CcSEcCtD
Amsacrine—Anorexia—Fludarabine—lymphatic system cancer	0.000291	0.00193	CcSEcCtD
Amsacrine—Extravasation—Methotrexate—lymphatic system cancer	0.000291	0.00193	CcSEcCtD
Amsacrine—Weight increased—Mitoxantrone—lymphatic system cancer	0.000291	0.00193	CcSEcCtD
Amsacrine—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000289	0.00192	CcSEcCtD
Amsacrine—Proteinuria—Methotrexate—lymphatic system cancer	0.000289	0.00192	CcSEcCtD
Amsacrine—Feeling abnormal—Teniposide—lymphatic system cancer	0.000286	0.0019	CcSEcCtD
Amsacrine—Stomatitis—Vincristine—lymphatic system cancer	0.000285	0.00189	CcSEcCtD
Amsacrine—Protein urine present—Methotrexate—lymphatic system cancer	0.000285	0.00189	CcSEcCtD
Amsacrine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000284	0.00189	CcSEcCtD
Amsacrine—Renal failure—Mitoxantrone—lymphatic system cancer	0.00028	0.00186	CcSEcCtD
Amsacrine—Nausea—Mechlorethamine—lymphatic system cancer	0.00028	0.00186	CcSEcCtD
Amsacrine—Alopecia—Bleomycin—lymphatic system cancer	0.000279	0.00185	CcSEcCtD
Amsacrine—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000278	0.00184	CcSEcCtD
Amsacrine—Jaundice—Mitoxantrone—lymphatic system cancer	0.000278	0.00184	CcSEcCtD
Amsacrine—Haemoglobin—Carmustine—lymphatic system cancer	0.000277	0.00184	CcSEcCtD
Amsacrine—Urticaria—Teniposide—lymphatic system cancer	0.000276	0.00183	CcSEcCtD
Amsacrine—Haemorrhage—Carmustine—lymphatic system cancer	0.000275	0.00183	CcSEcCtD
Amsacrine—Body temperature increased—Teniposide—lymphatic system cancer	0.000275	0.00182	CcSEcCtD
Amsacrine—Abdominal pain—Teniposide—lymphatic system cancer	0.000275	0.00182	CcSEcCtD
Amsacrine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000274	0.00182	CcSEcCtD
Amsacrine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000274	0.00182	CcSEcCtD
Amsacrine—Hyperuricaemia—Methotrexate—lymphatic system cancer	0.000274	0.00182	CcSEcCtD
Amsacrine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000272	0.00181	CcSEcCtD
Amsacrine—Haematuria—Mitoxantrone—lymphatic system cancer	0.000272	0.0018	CcSEcCtD
Amsacrine—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00027	0.0018	CcSEcCtD
Amsacrine—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000269	0.0634	CbGdCrCtD
Amsacrine—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000266	0.00177	CcSEcCtD
Amsacrine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000266	0.00176	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000264	0.00175	CcSEcCtD
Amsacrine—Fatigue—Fludarabine—lymphatic system cancer	0.000263	0.00175	CcSEcCtD
Amsacrine—Inflammation—Methotrexate—lymphatic system cancer	0.000262	0.00174	CcSEcCtD
Amsacrine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000261	0.00174	CcSEcCtD
Amsacrine—Pain—Fludarabine—lymphatic system cancer	0.000261	0.00173	CcSEcCtD
Amsacrine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00026	0.00173	CcSEcCtD
Amsacrine—Urinary tract disorder—Vincristine—lymphatic system cancer	0.000259	0.00172	CcSEcCtD
Amsacrine—Blood uric acid increased—Methotrexate—lymphatic system cancer	0.000258	0.00172	CcSEcCtD
Amsacrine—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000258	0.00171	CcSEcCtD
Amsacrine—Urethral disorder—Vincristine—lymphatic system cancer	0.000258	0.00171	CcSEcCtD
Amsacrine—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000257	0.00171	CcSEcCtD
Amsacrine—Hypersensitivity—Teniposide—lymphatic system cancer	0.000256	0.0017	CcSEcCtD
Amsacrine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.000256	0.0017	CcSEcCtD
Amsacrine—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000256	0.0017	CcSEcCtD
Amsacrine—Anaemia—Bleomycin—lymphatic system cancer	0.000254	0.00168	CcSEcCtD
Amsacrine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000252	0.00167	CcSEcCtD
Amsacrine—Asthenia—Teniposide—lymphatic system cancer	0.000249	0.00166	CcSEcCtD
Amsacrine—Arrhythmia—Carmustine—lymphatic system cancer	0.000246	0.00163	CcSEcCtD
Amsacrine—Leukopenia—Bleomycin—lymphatic system cancer	0.000246	0.00163	CcSEcCtD
Amsacrine—Cardiac disorder—Vincristine—lymphatic system cancer	0.000244	0.00162	CcSEcCtD
Amsacrine—Alopecia—Carmustine—lymphatic system cancer	0.000243	0.00161	CcSEcCtD
Amsacrine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000242	0.0016	CcSEcCtD
Amsacrine—Mental disorder—Carmustine—lymphatic system cancer	0.000241	0.0016	CcSEcCtD
Amsacrine—Malnutrition—Carmustine—lymphatic system cancer	0.00024	0.00159	CcSEcCtD
Amsacrine—Angiopathy—Vincristine—lymphatic system cancer	0.000238	0.00158	CcSEcCtD
Amsacrine—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000238	0.00158	CcSEcCtD
Amsacrine—Diarrhoea—Teniposide—lymphatic system cancer	0.000238	0.00158	CcSEcCtD
Amsacrine—Mediastinal disorder—Vincristine—lymphatic system cancer	0.000237	0.00157	CcSEcCtD
Amsacrine—Alopecia—Vincristine—lymphatic system cancer	0.000232	0.00154	CcSEcCtD
Amsacrine—Mental disorder—Vincristine—lymphatic system cancer	0.00023	0.00153	CcSEcCtD
Amsacrine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000229	0.00152	CcSEcCtD
Amsacrine—Alopecia—Mitoxantrone—lymphatic system cancer	0.000226	0.0015	CcSEcCtD
Amsacrine—Confusional state—Bleomycin—lymphatic system cancer	0.000226	0.0015	CcSEcCtD
Amsacrine—Vision blurred—Carmustine—lymphatic system cancer	0.000226	0.0015	CcSEcCtD
Amsacrine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000225	0.00149	CcSEcCtD
Amsacrine—Infection—Bleomycin—lymphatic system cancer	0.000223	0.00148	CcSEcCtD
Amsacrine—Anaemia—Carmustine—lymphatic system cancer	0.000221	0.00147	CcSEcCtD
Amsacrine—Vomiting—Teniposide—lymphatic system cancer	0.000221	0.00147	CcSEcCtD
Amsacrine—Sepsis—Methotrexate—lymphatic system cancer	0.00022	0.00146	CcSEcCtD
Amsacrine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000219	0.00146	CcSEcCtD
Amsacrine—Asthenia—Fludarabine—lymphatic system cancer	0.000219	0.00145	CcSEcCtD
Amsacrine—Rash—Teniposide—lymphatic system cancer	0.000219	0.00145	CcSEcCtD
Amsacrine—Dermatitis—Teniposide—lymphatic system cancer	0.000219	0.00145	CcSEcCtD
Amsacrine—Headache—Teniposide—lymphatic system cancer	0.000218	0.00145	CcSEcCtD
Amsacrine—Leukopenia—Carmustine—lymphatic system cancer	0.000214	0.00142	CcSEcCtD
Amsacrine—Anorexia—Bleomycin—lymphatic system cancer	0.000214	0.00142	CcSEcCtD
Amsacrine—Anaemia—Vincristine—lymphatic system cancer	0.000211	0.0014	CcSEcCtD
Amsacrine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00021	0.00139	CcSEcCtD
Amsacrine—Hypotension—Bleomycin—lymphatic system cancer	0.000209	0.00139	CcSEcCtD
Amsacrine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000209	0.00139	CcSEcCtD
Amsacrine—Convulsion—Carmustine—lymphatic system cancer	0.000208	0.00138	CcSEcCtD
Amsacrine—Nausea—Teniposide—lymphatic system cancer	0.000206	0.00137	CcSEcCtD
Amsacrine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000206	0.00137	CcSEcCtD
Amsacrine—Hepatic failure—Methotrexate—lymphatic system cancer	0.000205	0.00136	CcSEcCtD
Amsacrine—Leukopenia—Vincristine—lymphatic system cancer	0.000205	0.00136	CcSEcCtD
Amsacrine—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000204	0.048	CbGdCrCtD
Amsacrine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000201	0.00134	CcSEcCtD
Amsacrine—Dyspnoea—Bleomycin—lymphatic system cancer	0.0002	0.00133	CcSEcCtD
Amsacrine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000199	0.00132	CcSEcCtD
Amsacrine—Convulsion—Vincristine—lymphatic system cancer	0.000198	0.00132	CcSEcCtD
Amsacrine—Confusional state—Carmustine—lymphatic system cancer	0.000197	0.00131	CcSEcCtD
Amsacrine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000195	0.00129	CcSEcCtD
Amsacrine—Infection—Carmustine—lymphatic system cancer	0.000194	0.00129	CcSEcCtD
Amsacrine—Vomiting—Fludarabine—lymphatic system cancer	0.000194	0.00129	CcSEcCtD
Amsacrine—Convulsion—Mitoxantrone—lymphatic system cancer	0.000193	0.00128	CcSEcCtD
Amsacrine—Rash—Fludarabine—lymphatic system cancer	0.000193	0.00128	CcSEcCtD
Amsacrine—Dermatitis—Fludarabine—lymphatic system cancer	0.000192	0.00128	CcSEcCtD
Amsacrine—Pain—Bleomycin—lymphatic system cancer	0.000192	0.00127	CcSEcCtD
Amsacrine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000191	0.00127	CcSEcCtD
Amsacrine—Headache—Fludarabine—lymphatic system cancer	0.000191	0.00127	CcSEcCtD
Amsacrine—Tachycardia—Carmustine—lymphatic system cancer	0.000191	0.00127	CcSEcCtD
Amsacrine—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000188	0.0444	CbGdCrCtD
Amsacrine—Lethargy—Methotrexate—lymphatic system cancer	0.000188	0.00125	CcSEcCtD
Amsacrine—Anorexia—Carmustine—lymphatic system cancer	0.000186	0.00124	CcSEcCtD
Amsacrine—Infection—Vincristine—lymphatic system cancer	0.000185	0.00123	CcSEcCtD
Amsacrine—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000185	0.0436	CbGdCrCtD
Amsacrine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000185	0.00123	CcSEcCtD
Amsacrine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000183	0.00122	CcSEcCtD
Amsacrine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000183	0.00121	CcSEcCtD
Amsacrine—Hypotension—Carmustine—lymphatic system cancer	0.000183	0.00121	CcSEcCtD
Amsacrine—Nausea—Fludarabine—lymphatic system cancer	0.000181	0.0012	CcSEcCtD
Amsacrine—Infection—Mitoxantrone—lymphatic system cancer	0.000181	0.0012	CcSEcCtD
Amsacrine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000178	0.00118	CcSEcCtD
Amsacrine—Urticaria—Bleomycin—lymphatic system cancer	0.000178	0.00118	CcSEcCtD
Amsacrine—Anorexia—Vincristine—lymphatic system cancer	0.000178	0.00118	CcSEcCtD
Amsacrine—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000178	0.0419	CbGdCrCtD
Amsacrine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000177	0.00118	CcSEcCtD
Amsacrine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000177	0.00118	CcSEcCtD
Amsacrine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000177	0.00117	CcSEcCtD
Amsacrine—Paraesthesia—Carmustine—lymphatic system cancer	0.000176	0.00117	CcSEcCtD
Amsacrine—Mood swings—Methotrexate—lymphatic system cancer	0.000175	0.00116	CcSEcCtD
Amsacrine—Hypotension—Vincristine—lymphatic system cancer	0.000174	0.00116	CcSEcCtD
Amsacrine—Dyspnoea—Carmustine—lymphatic system cancer	0.000174	0.00116	CcSEcCtD
Amsacrine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000173	0.00115	CcSEcCtD
Amsacrine—Decreased appetite—Carmustine—lymphatic system cancer	0.00017	0.00113	CcSEcCtD
Amsacrine—Hypotension—Mitoxantrone—lymphatic system cancer	0.00017	0.00113	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000169	0.00112	CcSEcCtD
Amsacrine—Paraesthesia—Vincristine—lymphatic system cancer	0.000168	0.00111	CcSEcCtD
Amsacrine—Pain—Carmustine—lymphatic system cancer	0.000167	0.00111	CcSEcCtD
Amsacrine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000165	0.0011	CcSEcCtD
Amsacrine—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.000165	0.0388	CbGdCrCtD
Amsacrine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000163	0.00108	CcSEcCtD
Amsacrine—Decreased appetite—Vincristine—lymphatic system cancer	0.000162	0.00108	CcSEcCtD
Amsacrine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000162	0.00108	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000161	0.00107	CcSEcCtD
Amsacrine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000161	0.00107	CcSEcCtD
Amsacrine—Fatigue—Vincristine—lymphatic system cancer	0.000161	0.00107	CcSEcCtD
Amsacrine—Asthenia—Bleomycin—lymphatic system cancer	0.000161	0.00107	CcSEcCtD
Amsacrine—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.00016	0.0378	CbGdCrCtD
Amsacrine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00016	0.00106	CcSEcCtD
Amsacrine—Pain—Vincristine—lymphatic system cancer	0.00016	0.00106	CcSEcCtD
Amsacrine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000158	0.00105	CcSEcCtD
Amsacrine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000157	0.00104	CcSEcCtD
Amsacrine—Pain—Mitoxantrone—lymphatic system cancer	0.000155	0.00103	CcSEcCtD
Amsacrine—Abdominal pain—Carmustine—lymphatic system cancer	0.000155	0.00103	CcSEcCtD
Amsacrine—Body temperature increased—Carmustine—lymphatic system cancer	0.000155	0.00103	CcSEcCtD
Amsacrine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000153	0.00101	CcSEcCtD
Amsacrine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000151	0.001	CcSEcCtD
Amsacrine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00015	0.000994	CcSEcCtD
Amsacrine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000149	0.000987	CcSEcCtD
Amsacrine—Abdominal pain—Vincristine—lymphatic system cancer	0.000148	0.000979	CcSEcCtD
Amsacrine—Body temperature increased—Vincristine—lymphatic system cancer	0.000148	0.000979	CcSEcCtD
Amsacrine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000144	0.000959	CcSEcCtD
Amsacrine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000144	0.000956	CcSEcCtD
Amsacrine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000144	0.000954	CcSEcCtD
Amsacrine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000144	0.000954	CcSEcCtD
Amsacrine—Vomiting—Bleomycin—lymphatic system cancer	0.000142	0.000945	CcSEcCtD
Amsacrine—Infestation—Methotrexate—lymphatic system cancer	0.000142	0.000943	CcSEcCtD
Amsacrine—Infestation NOS—Methotrexate—lymphatic system cancer	0.000142	0.000943	CcSEcCtD
Amsacrine—Rash—Bleomycin—lymphatic system cancer	0.000141	0.000938	CcSEcCtD
Amsacrine—Dermatitis—Bleomycin—lymphatic system cancer	0.000141	0.000937	CcSEcCtD
Amsacrine—Asthenia—Carmustine—lymphatic system cancer	0.00014	0.000931	CcSEcCtD
Amsacrine—Renal failure—Methotrexate—lymphatic system cancer	0.00014	0.000927	CcSEcCtD
Amsacrine—Stomatitis—Methotrexate—lymphatic system cancer	0.000138	0.000919	CcSEcCtD
Amsacrine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000138	0.000913	CcSEcCtD
Amsacrine—Haematuria—Methotrexate—lymphatic system cancer	0.000135	0.000899	CcSEcCtD
Amsacrine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000134	0.000891	CcSEcCtD
Amsacrine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000134	0.000889	CcSEcCtD
Amsacrine—Asthenia—Vincristine—lymphatic system cancer	0.000134	0.000889	CcSEcCtD
Amsacrine—Diarrhoea—Carmustine—lymphatic system cancer	0.000134	0.000888	CcSEcCtD
Amsacrine—Nausea—Bleomycin—lymphatic system cancer	0.000133	0.000883	CcSEcCtD
Amsacrine—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000133	0.00088	CcSEcCtD
Amsacrine—Asthenia—Mitoxantrone—lymphatic system cancer	0.00013	0.000866	CcSEcCtD
Amsacrine—Dizziness—Carmustine—lymphatic system cancer	0.000129	0.000858	CcSEcCtD
Amsacrine—Haemoglobin—Methotrexate—lymphatic system cancer	0.000128	0.00085	CcSEcCtD
Amsacrine—Diarrhoea—Vincristine—lymphatic system cancer	0.000128	0.000848	CcSEcCtD
Amsacrine—Hepatitis—Methotrexate—lymphatic system cancer	0.000127	0.000846	CcSEcCtD
Amsacrine—Haemorrhage—Methotrexate—lymphatic system cancer	0.000127	0.000846	CcSEcCtD
Amsacrine—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000126	0.000836	CcSEcCtD
Amsacrine—Urethral disorder—Methotrexate—lymphatic system cancer	0.000125	0.000829	CcSEcCtD
Amsacrine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000124	0.000826	CcSEcCtD
Amsacrine—Vomiting—Carmustine—lymphatic system cancer	0.000124	0.000825	CcSEcCtD
Amsacrine—Dizziness—Vincristine—lymphatic system cancer	0.000123	0.000819	CcSEcCtD
Amsacrine—Rash—Carmustine—lymphatic system cancer	0.000123	0.000818	CcSEcCtD
Amsacrine—Dermatitis—Carmustine—lymphatic system cancer	0.000123	0.000818	CcSEcCtD
Amsacrine—Headache—Carmustine—lymphatic system cancer	0.000122	0.000813	CcSEcCtD
Amsacrine—Vomiting—Vincristine—lymphatic system cancer	0.000119	0.000788	CcSEcCtD
Amsacrine—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000118	0.000785	CcSEcCtD
Amsacrine—Rash—Vincristine—lymphatic system cancer	0.000118	0.000781	CcSEcCtD
Amsacrine—Dermatitis—Vincristine—lymphatic system cancer	0.000118	0.00078	CcSEcCtD
Amsacrine—Headache—Vincristine—lymphatic system cancer	0.000117	0.000776	CcSEcCtD
Amsacrine—Nausea—Carmustine—lymphatic system cancer	0.000116	0.000771	CcSEcCtD
Amsacrine—Angiopathy—Methotrexate—lymphatic system cancer	0.000116	0.000768	CcSEcCtD
Amsacrine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000116	0.000767	CcSEcCtD
Amsacrine—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000115	0.000763	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000115	0.0271	CbGdCrCtD
Amsacrine—Rash—Mitoxantrone—lymphatic system cancer	0.000115	0.000761	CcSEcCtD
Amsacrine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000115	0.00076	CcSEcCtD
Amsacrine—Headache—Mitoxantrone—lymphatic system cancer	0.000114	0.000756	CcSEcCtD
Amsacrine—Alopecia—Methotrexate—lymphatic system cancer	0.000113	0.000748	CcSEcCtD
Amsacrine—Mental disorder—Methotrexate—lymphatic system cancer	0.000112	0.000741	CcSEcCtD
Amsacrine—Malnutrition—Methotrexate—lymphatic system cancer	0.000111	0.000737	CcSEcCtD
Amsacrine—Nausea—Vincristine—lymphatic system cancer	0.000111	0.000736	CcSEcCtD
Amsacrine—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000108	0.0256	CbGdCrCtD
Amsacrine—Nausea—Mitoxantrone—lymphatic system cancer	0.000108	0.000717	CcSEcCtD
Amsacrine—Vision blurred—Methotrexate—lymphatic system cancer	0.000105	0.000694	CcSEcCtD
Amsacrine—Anaemia—Methotrexate—lymphatic system cancer	0.000103	0.000681	CcSEcCtD
Amsacrine—Leukopenia—Methotrexate—lymphatic system cancer	9.93e-05	0.000659	CcSEcCtD
Amsacrine—Convulsion—Methotrexate—lymphatic system cancer	9.61e-05	0.000638	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	9.38e-05	0.000623	CcSEcCtD
Amsacrine—Confusional state—Methotrexate—lymphatic system cancer	9.13e-05	0.000606	CcSEcCtD
Amsacrine—Infection—Methotrexate—lymphatic system cancer	9e-05	0.000597	CcSEcCtD
Amsacrine—Thrombocytopenia—Methotrexate—lymphatic system cancer	8.87e-05	0.000589	CcSEcCtD
Amsacrine—Skin disorder—Methotrexate—lymphatic system cancer	8.8e-05	0.000584	CcSEcCtD
Amsacrine—Anorexia—Methotrexate—lymphatic system cancer	8.63e-05	0.000573	CcSEcCtD
Amsacrine—Hypotension—Methotrexate—lymphatic system cancer	8.46e-05	0.000562	CcSEcCtD
Amsacrine—Paraesthesia—Methotrexate—lymphatic system cancer	8.13e-05	0.00054	CcSEcCtD
Amsacrine—Dyspnoea—Methotrexate—lymphatic system cancer	8.07e-05	0.000536	CcSEcCtD
Amsacrine—Decreased appetite—Methotrexate—lymphatic system cancer	7.87e-05	0.000523	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	7.82e-05	0.000519	CcSEcCtD
Amsacrine—Fatigue—Methotrexate—lymphatic system cancer	7.81e-05	0.000518	CcSEcCtD
Amsacrine—Pain—Methotrexate—lymphatic system cancer	7.74e-05	0.000514	CcSEcCtD
Amsacrine—Feeling abnormal—Methotrexate—lymphatic system cancer	7.46e-05	0.000495	CcSEcCtD
Amsacrine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	7.41e-05	0.000492	CcSEcCtD
Amsacrine—Urticaria—Methotrexate—lymphatic system cancer	7.19e-05	0.000478	CcSEcCtD
Amsacrine—Abdominal pain—Methotrexate—lymphatic system cancer	7.16e-05	0.000475	CcSEcCtD
Amsacrine—Body temperature increased—Methotrexate—lymphatic system cancer	7.16e-05	0.000475	CcSEcCtD
Amsacrine—Hypersensitivity—Methotrexate—lymphatic system cancer	6.67e-05	0.000443	CcSEcCtD
Amsacrine—Asthenia—Methotrexate—lymphatic system cancer	6.5e-05	0.000431	CcSEcCtD
Amsacrine—Diarrhoea—Methotrexate—lymphatic system cancer	6.2e-05	0.000411	CcSEcCtD
Amsacrine—Dizziness—Methotrexate—lymphatic system cancer	5.99e-05	0.000398	CcSEcCtD
Amsacrine—Vomiting—Methotrexate—lymphatic system cancer	5.76e-05	0.000382	CcSEcCtD
Amsacrine—Rash—Methotrexate—lymphatic system cancer	5.71e-05	0.000379	CcSEcCtD
Amsacrine—Dermatitis—Methotrexate—lymphatic system cancer	5.7e-05	0.000379	CcSEcCtD
Amsacrine—Headache—Methotrexate—lymphatic system cancer	5.67e-05	0.000377	CcSEcCtD
Amsacrine—Nausea—Methotrexate—lymphatic system cancer	5.38e-05	0.000357	CcSEcCtD
